Loading
Berlin gynaecological oncologist and ESGO President, a leading ovarian cancer surgeon and trialist within the AGO study group.
Jalid Sehouli is President of the European Society of Gynaecological Oncology (ESGO) and Director of the Department of Gynecology at Charité University Hospital, Berlin. He is a leading investigator in ovarian cancer surgery and systemic therapy and a co-author of the DESKTOP III trial of secondary cytoreductive surgery for relapsed ovarian cancer. He has long been active in the AGO Study Group and in international ovarian cancer trial collaborations.
| Title | Journal | Year |
|---|---|---|
| Randomized Trial of Cytoreductive Surgery for Relapsed Ovarian Cancer | New England Journal of Medicine | 2021 |
Shares European Society of Gynaecological Oncology, Endometrial cancer, Ovarian cancer and the tags leadership, clinician-scientist, gynaecological oncology.
Shares Endometrial cancer, Cervical cancer, Ovarian cancer and the tags leadership, clinician-scientist, gynaecological oncology, ovarian cancer.
Shares Endometrial cancer, Cervical cancer, Ovarian cancer and the tags leadership, clinician-scientist, ovarian cancer.
Shares Endometrial cancer, Cervical cancer, Ovarian cancer and the tag leadership.
Shares Endometrial cancer, Ovarian cancer and the tags leadership, clinician-scientist.
Shares Ovarian cancer and the tags leadership, clinician-scientist, ovarian cancer.
Shares Endometrial cancer, Ovarian cancer and the tags leadership, clinician-scientist, gynaecological oncology.
Shares Endometrial cancer, Ovarian cancer and the tags leadership, clinician-scientist.